02/04/2026
Tetum Below
Timor-Leste continues to receive support from the Global Fund to combat HIV/AIDS and Tuberculosis (TB). For Grant Cycle 8 (GC8: 2027–2029), Timor-Leste has been allocated a total amount of USD 8,549,183.
This funding will focus exclusively on HIV/AIDS, TB programs and Resilient and Sustainable Systems for Health (RSSH). Timor-Leste no longer receives funding for malaria, as the country has successfully achieved malaria-free certification from the World Health Organization. As a result, the total allocation for this cycle has decreased by approximately 45% compared to the previous cycle.
Following the receipt of the Allocation Letter from the CCM Hub, the Country Coordinating Mechanism Timor-Leste (CCM-TL) held a regular meeting on April 1, 2026, at the WHO Meeting Room. The meeting involved CCM members, the Proposal Development Committee, representatives from WHO, and the Global Fund Division of the Ministry of Health.
The objectives of the meeting were to discuss and approve the following key points:
• PR Application Approach
• Nomination of the Principal Recipient (PR)
• Proposal Submission Timeline
• Allocation of funds by program
Key decisions made:
• CCM-TL agreed to adopt the Grant-Ready PR Application Approach, with the Ministry of Health serving as the main implementer
• The Ministry of Health was officially nominated as the Principal Recipient (PR) for the 2027–2029 period
• Proposal submission is scheduled for June 1, 2026 (Window 1)
• Fund allocation:
o HIV/AIDS: USD 2,407,422
o Tuberculosis (TB): USD 5,891,861
o Resilient and Sustainable Systems for Health. (RSSH): USD 250,000
Total: USD 8,549,183
This marks an important step in strengthening Timor-Leste’s health system and continuing efforts to combat HIV and TB.
__________________________________________________
Timor-Leste kontinua hetan apoiu husi Global Fund hodi kombate moras HIV/AIDS no Tuberkulose (TB). Ba Grant Cycle 8 (GC8: 2027–2029), Timor-Leste simu alokasaun hamutuk montante USD 8,549,183.
Fundu ida ne’e sei foka de’it ba programa HIV/AIDS , TB no RSSH, ba Malaria nian Timor-Leste la hetan ona apoiu fundos tanba ita susesu hetan ona sertifikasaun livre Malaria husi WHO. Ho situasaun ida ne’e, total alokasaun ba siklu ida ne’e menus, quase 45% kompara ho siklu uluk.
Depois simu Allocation Letter husi CCM Hub, Country Coordinating Mechanism Timor-Leste (CCM-TL) hala’o reuniaun regular ida iha loron 1 Abril 2026 iha WHO Meeting Room. Reuniaun ne’e involve membru sira CCM, Proposal Development Committee, reprezentante WHO, no Divizaun Global Fund husi Ministeriu Saude.
Objetivu husi reuniaun mak diskuti no aprova pontu importante sira tuir mai:
• PR Application Approach
• Nomeasaun Principal Recipient (PR)
• Timeline Submisaun Proposta
• Fahe Fundu ba kada programa
Desizaun importante sira:
• CCM-TL konkorda atu uza Grant-Ready PR Application Approach, ne’ebé Ministeriu Saude sei sai implementadór principal
• Ministeriu Saude nomeadu ofisialmente hanesan Principal Recipient (PR) ba períodu 2027–20294*
• Submisaun proposta marka ba 1 Juñu 2026 (Window 1)
• Fahe fundu:
o HIV/AIDS: USD 2,407,422
o Tuberkulose (TB): USD 5,891,861
o Resilient and Sustainable Systems for Health (RSSH): USD 250,000
Total: USD 8,549,183
Ne’e sai pasu importante ida atu reforsa sistema saude Timor-Leste no kontinua esforsu iha kombate HIV no TB.